The Law Offices of Vincent Wong Announce an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspire Pharmaceuticals, Inc. in Connection with the Sale of the Company to Merck – ISPH

The Law Offices of Vincent Wong are investigating the Board of Directors of Inspire Pharmaceuticals, Inc. (Nasdaq: ISPH) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Merck (NYSE: MRK). Under the terms of the deal, Inspire shareholders will receive $5.00 in cash per share of Inspire stock. The transaction has a total value of approximately $430 million.

The investigation concerns whether the Inspire Board of Directors breached their fiduciary duties to Inspire stockholders by failing to adequately shop the Company before entering into this transaction and whether Merck is underpaying for Inspire shares. According to Thomson/First Call, at least one analyst set a price target of $10.00 for Inspire shares.

If you own common stock in Inspire and wish to obtain additional information, please contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.584.2740, or visit http://www.wongesq.com/inspire-pharmaceuticals.html.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel: 212-584-2740
Fax: 866-367-6510
vw@wongesq.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.